SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000892569-05-000877
Filing Date
2005-10-07
Accepted
2005-10-07 17:29:41
Documents
13
Period of Report
2005-10-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K a13312e8vk.htm 8-K 34232
2 EXHIBIT 4.1 a13312exv4w1.txt EX-4.1 88390
3 EXHIBIT 4.2 a13312exv4w2.txt EX-4.2 52201
4 EXHIBIT 10.1 a13312exv10w1.txt EX-10.1 277851
5 EXHIBIT 10.2 a13312exv10w2.txt EX-10.2 21064
6 EXHIBIT 10.3 a13312exv10w3.txt EX-10.3 20255
7 EXHIBIT 10.4 a13312exv10w4.txt EX-10.4 20227
8 EXHIBIT 10.5 a13312exv10w5.txt EX-10.5 20241
9 EXHIBIT 10.6 a13312exv10w6.txt EX-10.6 20216
10 EXHIBIT 10.7 a13312exv10w7.txt EX-10.7 20149
11 EXHIBIT 10.8 a13312exv10w8.txt EX-10.8 20176
12 EXHIBIT 10.9 a13312exv10w9.txt EX-10.9 20226
13 EXHIBIT 99.1 a13312exv99w1.txt EX-99.1 4694
  Complete submission text file 0000892569-05-000877.txt   621560
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24274 | Film No.: 051130374
SIC: 2836 Biological Products, (No Diagnostic Substances)